M S Hofman

Summary

Affiliation: Peter MacCallum Cancer Centre
Country: Australia

Publications

  1. doi request reprint 68Ga-EDTA PET/CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification: Comparison to Conventional 51Cr-EDTA
    Michael Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia Department of Medicine, University of Melbourne, Melbourne, Australia
    J Nucl Med 56:405-9. 2015
  2. pmc A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer
    Shankar Siva
    Division of Radiation Oncology and Cancer Imaging, St Andrews Place, East Melbourne 3002, Australia
    BMC Cancer 14:740. 2014
  3. doi request reprint Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT
    Roderick J Clifton-Bligh
    Cancer Genetics Unit, Hormones and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, New South Wales 2065, Australia
    J Clin Endocrinol Metab 98:687-94. 2013
  4. doi request reprint High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
    Michael S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia
    J Med Imaging Radiat Oncol 56:40-7. 2012
  5. pmc White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
    Michael S Hofman
    Center for Cancer Imaging, Peter MacCallum Cancer Centre, St, Andrews Place, East Melbourne, VIC 3002 Australia
    EJNMMI Res 1:2. 2011
  6. doi request reprint 68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy
    Michael S Hofman
    Molecular Imaging, Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    J Nucl Med 52:1513-9. 2011
  7. doi request reprint Imaging in follicular NHL
    M S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    Best Pract Res Clin Haematol 24:165-77. 2011
  8. pmc Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)
    G Kong
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, St Andrew s Place, East Melbourne, Vic, 3002, Australia
    Eur J Nucl Med Mol Imaging 41:1831-44. 2014
  9. pmc Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
    C Y Cheah
    Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia
    Br J Cancer 109:312-7. 2013
  10. doi request reprint The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable
    T W Barber
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia
    Eur J Surg Oncol 38:64-71. 2012

Collaborators

Detail Information

Publications10

  1. doi request reprint 68Ga-EDTA PET/CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification: Comparison to Conventional 51Cr-EDTA
    Michael Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia Department of Medicine, University of Melbourne, Melbourne, Australia
    J Nucl Med 56:405-9. 2015
    ..This study aimed to assess agreement between (68)Ga-EDTA GFR ((68)Ga-GFR) and (51)Cr-EDTA GFR ((51)Cr-GFR), using serial plasma sampling and PET imaging...
  2. pmc A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer
    Shankar Siva
    Division of Radiation Oncology and Cancer Imaging, St Andrews Place, East Melbourne 3002, Australia
    BMC Cancer 14:740. 2014
    ..The ability to intensify treatment to achieve a better chance for cure is limited by the risk of injury to the surrounding lung...
  3. doi request reprint Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT
    Roderick J Clifton-Bligh
    Cancer Genetics Unit, Hormones and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, New South Wales 2065, Australia
    J Clin Endocrinol Metab 98:687-94. 2013
    ..Tumors secreting fibroblast growth factor 23 are often small and difficult to find with conventional imaging...
  4. doi request reprint High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
    Michael S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia
    J Med Imaging Radiat Oncol 56:40-7. 2012
    ..This study assesses the management impact of incremental diagnostic information obtained from this technique compared with conventional staging...
  5. pmc White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
    Michael S Hofman
    Center for Cancer Imaging, Peter MacCallum Cancer Centre, St, Andrews Place, East Melbourne, VIC 3002 Australia
    EJNMMI Res 1:2. 2011
    ..We discuss the potential biological basis of this finding and provide recommendations on the avoidance of this complication...
  6. doi request reprint 68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy
    Michael S Hofman
    Molecular Imaging, Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    J Nucl Med 52:1513-9. 2011
    ..This pilot study assessed the feasibility of performing V/Q PET/CT and compared diagnostic utility with conventional V/Q imaging in patients with clinical suspicion of PE...
  7. doi request reprint Imaging in follicular NHL
    M S Hofman
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
    Best Pract Res Clin Haematol 24:165-77. 2011
    ..Molecular imaging is likely to play an increasing role in selection of patients for specific treatments and in prognostic stratification...
  8. pmc Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)
    G Kong
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, St Andrew s Place, East Melbourne, Vic, 3002, Australia
    Eur J Nucl Med Mol Imaging 41:1831-44. 2014
    ....
  9. pmc Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
    C Y Cheah
    Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia
    Br J Cancer 109:312-7. 2013
    ..The usefulness of positron emission tomography with computed tomography (PET-CT) in the surveillance of patients with diffuse large B-cell lymphoma (DLBCL) in complete metabolic remission after primary therapy is not well studied...
  10. doi request reprint The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable
    T W Barber
    Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia
    Eur J Surg Oncol 38:64-71. 2012
    ....